Zinc Oxide Concentrate
NDC Package 50765-4702-4

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Zinc Oxide concentrates is a medication used to treat and prevent diaper rash and other minor skin irritations (e.g., burns, cuts, scrapes). This formulation utilizes a concentrate delivery system. Marketed by Symrise Inc, this product is identified by NDC 50765-4702.

Identification & Billing

NDC Package Code
50765-4702-4
Package Description
1 BAG in 1 BOX / 25 kg in 1 BAG
Product Code
50765-4702
11-Digit Billing Format
50765470204

Clinical Specifications

Proprietary Name
Zinc Oxide
Non-Proprietary Name
Zinc Oxide
Substance Name
Zinc Oxide
Dosage Form
Concentrate - A liquid preparation of increased strength and reduced volume which is usually diluted prior to administration.
Active Ingredient(s)
ZINC OXIDE 1 kg/kg
Usage Information
This medication is used to treat and prevent diaper rash and other minor skin irritations (e.g., burns, cuts, scrapes). It works by forming a barrier on the skin to protect it from irritants/moisture.

Regulatory & Marketing

Labeler Name
Symrise Inc
Product Type
Bulk Ingredient
Marketing Category
BULK INGREDIENT - A category specifying that a product is marketed as a bulk ingredient.
Start Marketing Date
09-01-2017
Listing Expiration
12-31-2026
Exclude Flag
N
Unfinished Product
Yes
Sample Package
N/A

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 50765-4702-4 identifies a specific commercial package of 1 bag in 1 box / 25 kg in 1 bag of Zinc Oxide (UNFINISHED drug), a bulk ingredient labeled by Symrise Inc. This concentrate is formulated for use and contains zinc oxide as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Symrise Inc on September 01, 2017. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This medication is used to treat and prevent diaper rash and other minor skin irritations (e.g., burns, cuts, scrapes). It works by forming a barrier on the skin to protect it from irritants/moisture.

How is this Symrise Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 50765470204. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
50765-4702-4
11-Digit CMS (5-4-2)
50765-4702-04

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.